BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12884358)

  • 1. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
    Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
    NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
    Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
    J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
    Wyska E; Pekala E; Szymura-Oleksiak J
    Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the concentrations of niflumic acid in the plasma and synovial tissue following repeated administration of capsules].
    Dorfmann H; Gendron A; Duchenne P
    Rev Rhum Mal Osteoartic; 1987 Apr; 54(4):339-41. PubMed ID: 3602910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.
    Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR
    Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS). Studies in the SCCVII/C3H murine model.
    Papadopoulou MV; Pouremad R; Bloomer WD; Wyrwicz A
    Anticancer Res; 2006; 26(5A):3259-63. PubMed ID: 17094438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
    Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
    Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
    Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (19)F NMR spectroscopic characterization of the interaction of niflumic acid with human serum albumin.
    Kitamura K; Omran AA; Takegami S; Tanaka R; Kitade T
    Anal Bioanal Chem; 2007 Apr; 387(8):2843-8. PubMed ID: 17377783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability studies of some glycolamide ester prodrugs of niflumic acid in aqueous buffers and human plasma by HPLC with UV detection.
    Talath S; Shirote PJ; Lough WJ; Gadad AK
    Arzneimittelforschung; 2006; 56(9):631-9. PubMed ID: 17063638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of trans-1,1,1,3-tetrafluoropropene (HFO-1234ze).
    Schuster P; Bertermann R; Rusch GM; Dekant W
    Toxicol Appl Pharmacol; 2009 Sep; 239(3):215-23. PubMed ID: 19573548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration.
    Völkel W; Colnot T; Schauer UM; Broschard TH; Dekant W
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):331-8. PubMed ID: 16806338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular binding of the anti-inflammatory drug niflumic acid in the liver.
    Kelmer-Bracht AM; Ishii-Iwamoto EL; Bracht A
    Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):411-9. PubMed ID: 8680809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change in the plasma and urine levels of ionized fluorine under the influence of low doses of niflumic acid. Possible application to the treatment of osteoporosis].
    Prost A; Boiteau HL; Rossel-Renac F; Audran M; Caumon JP
    Rev Rhum Mal Osteoartic; 1980 Nov; 47(11):635-43. PubMed ID: 7444306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-steroidal anti-inflammatory agents and pregnancy. A study of renal and digestive toxicity of niflumic acid in the perinatal period].
    Alessandri JL; Abossolo T; Reynaud I; Montbrun A; Sommer JC; Tilmont P
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(7):813-8. PubMed ID: 7822716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species and gender differences in the formation of an active metabolite of a substituted 2,4-thiazolidinedione insulin sensitizer.
    Beconi M; Mao A; Creighton M; Hop CE; Chiu SH; Eydelloth R; Franklin R; Tang F; Yu N; Vincent S
    Xenobiotica; 2003 Jul; 33(7):767-87. PubMed ID: 12893525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of niflumic acid in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection and its application to a bioequivalence study of talniflumate tablets.
    Lee HW; Won KJ; Cho SH; Ha YH; Park WS; Yim HT; Baek M; Rew JH; Yoon SH; Yim SV; Chung JH; Lee KT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):215-20. PubMed ID: 15921965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation, identification and structure of a new hydroxylated metabolite of benzbromarone in man.
    De Vries JX; Walter-Sack I; Ittensohn A; Weber E
    Xenobiotica; 1989 Dec; 19(12):1461-70. PubMed ID: 2618093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid chromatography-mass spectrometric method for the sensitive determination of niflumic acid in human plasma and its application to pharmacokinetic study of talniflumate tablet.
    Park EJ; Na DH; Shin YH; Lee KC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):159-62. PubMed ID: 19010744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.